Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Predictable, dose- and time-independent PK for Arixtra in young and elderly subjects

Nov. 12, 2001

Development of beraprost for intermittent claudication expected to be dropped

Oct. 17, 2001

GlycoDesign and Leo move new antithrombotics into clinical trials

Oct. 15, 2001

Phase II trial of Argatroban plus gpIIb/IIIa antagonists initiated in patients undergoing PCI

Oct. 10, 2001

Avigen's Coagulin-B gene therapy for hemophilia B trial on clinical hold

Oct. 10, 2001

3-Dimensional Pharmaceuticals to receive milestone payment for thrombin inhibitor program

Oct. 10, 2001

Schering AG acquires rights to Refludan from Aventis

Oct. 9, 2001

Fujisawa reveals new antiplatelet agents

Oct. 8, 2001

NIH supports development of inhaled gene therapy for hemophilia B

Oct. 4, 2001

ProQuest receives grant to study oral formulations of peptides and peptidomimetics

Oct. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Makary out at the FDA
BioWorld
U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with...